Production (Stage)
Antiaging Quantum Living Inc.
AAQL
$0.75
-$0.06-7.41%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 2,352.38% | -- | 16,741.67% | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 2,352.38% | -- | 16,741.67% | -100.00% |
| Cost of Revenue | -- | 550.00% | -- | -- | -- |
| Gross Profit | -- | 2,614.55% | -- | 16,725.00% | -100.00% |
| SG&A Expenses | -62.61% | 239.28% | 1,361.48% | 1,245.63% | 3,016.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 78.61% | 241.68% | 1,420.08% | 1,246.28% | 3,016.67% |
| Operating Income | 31.47% | -104.74% | -710.66% | -620.20% | -3,536.11% |
| Income Before Tax | 31.40% | -33.06% | -710.25% | -620.20% | -3,536.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 31.40% | -33.06% | -710.25% | -620.20% | -3,536.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.40% | -33.06% | -710.25% | -620.20% | -3,536.11% |
| EBIT | 31.47% | -104.74% | -710.66% | -620.20% | -3,536.11% |
| EBITDA | 43.79% | -67.63% | -502.06% | -553.72% | -3,443.06% |
| EPS Basic | 31.03% | -34.38% | -725.00% | -610.00% | -4,250.00% |
| Normalized Basic EPS | 32.73% | -35.00% | -720.00% | -650.00% | -2,650.00% |
| EPS Diluted | 31.03% | -34.38% | -725.00% | -610.00% | -4,250.00% |
| Normalized Diluted EPS | 32.73% | -35.00% | -720.00% | -650.00% | -2,650.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | -0.13% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | -0.13% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |